任路瑤
工作經歷
研究方向
從組學標準物質研製、標準數據集構建、數據分析方法評估等方面進行深入研究，以確保組學數據質量和分析方法準確可靠，為腫瘤精準診療奠定基礎。
獲獎情況
復旦大學優秀畢業生（2021）
代表論文
1.Xiao W*#, Ren L*, Chen Z, Fang LT, Zhao Y, Lack J, Jaeger E, Kerrigan L, Blomquist T, Hung T, …, Wang C#, Shi L#. Towards best practice in cancer mutation detection with whole-genome and whole-exome sequencing. Nature Biotechnology, 39(9):1141-1150 (2021)
2.Fang LT*, Zhu B*, Zhao Y*, Chen W, Yang Z, Kerrigan L, Langenbach K, Mars M, Lu C, Idler K, Jacob H, Zheng Y, Ren L, …, Hong H#, Shi L#, Wang C#, Xiao W#. Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing. Nature Biotechnology, 39(9):1151-1160 (2021)
3.Zheng Y*, Li B*, Pan D*, Cao J, Zhang J, Wang X, Li X, Hou W, Bao D, Ren L, Yang J, Wang S, Qiu Y, Zhou F, Liu Z, Zhu S, Zhang L, Qing T, Wang Y, Yu Y, Wu J#, Hu X#, Shi L#. Functional consequences of a rare missense BARD1 c.403G>A germline mutation identified in a triple-negative breast cancer Patient. Breast Cancer Research, 23(1):53 (2021)
4.Jiang YZ*, Ma D*, Suo C*, Shi J*, Xue M, Hu X, Xiao Y, Yu KD, Liu YR, Yu Y, Zheng Y, Li X, Zhang C, Hu P, Zhang J, Hua Q, Zhang J, Hou W, Ren L, Bao D, …, Wang P#, Shi L#, Huang W#, Shao ZM#. Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies. Cancer Cell, 35(3):428-440 (2019)